NAD+ (Nicotinamide Adenine Dinucleotide)
NAD+ is a coenzyme found in every living cell that plays a central role in energy metabolism, DNA repair, and cellular signaling. NAD+ levels decline significantly with age, dropping by roughly 50% between the ages of 40 and 60. Restoring NAD+ levels through direct supplementation or precursors like NMN and NR has become a major focus of longevity research, with evidence supporting improvements in mitochondrial function, cognitive clarity, and metabolic health.
FormBlends Peptide Context
Reviewed May 14, 2026Use Nad Plus peptide guide as a decision-support page, not a shortcut. Its job is to frame benefits, dosing, evidence strength, sourcing, and safety boundaries in one place, especially where the search overlaps with peptide therapy. A useful reader should leave with better questions about clinician oversight, evidence quality, safety limits, cost, pharmacy path, and what changes for their own health history.
- Confirm whether the page is discussing approved care, compounded access, off-label use, or research-only context.
- Check the date, evidence quality, safety limits, and whether newer clinical or regulatory updates may change the answer.
- Ask a licensed clinician how the information applies to your history, medications, labs, goals, and risk profile.
Clinical decision snapshot
NAD+ authority snapshot
NAD+ is evaluated by mechanism, evidence quality, regulatory status, practical access, and safety questions a licensed clinician would need to review before use.
Evidence signal
Meaningful evidence with limits
Regulatory reality
Not affected by 2023 restrictions
Safety screen
Nausea during IV infusion if administered too quickly, Chest tightness or pressure during IV infusion, Cramping should be reviewed in context.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
Decision path
What is the supervised-review path for NAD+?
NAD+ should be evaluated by evidence quality, safety status, source quality, dosing context, and whether the goal fits a legitimate clinical pathway. This page is a research and decision aid, not a self-prescribing guide.
- Peptide
- NAD+
- Category
- Longevity
- Evidence
- Meaningful evidence with limits
- FDA status
- Not FDA approved
Step 1
Check evidence level
NAD+ has strong mechanistic science behind it and growing human clinical data. A 2022 randomized controlled trial published in Nature Aging showed that NMN supplementation (an NAD+ precursor) improved muscle insulin sensitivity in postmenopausal women. Several other human trials confirm NAD+ levels increase with supplementation. The longevity claims are still mostly based on animal models.
Review evidenceStep 2
Screen safety context
Nausea during IV infusion if administered too quickly, Chest tightness or pressure during IV infusion, Cramping should be discussed in light of history, dose, and source.
Check side effectsStep 3
Confirm access route
If FormBlends offers access, review the product page and provider pathway before deciding.
Review product accessLongevity decision hub
NAD+ pages should separate cellular biology from wellness claims
NAD+ has broad search demand because it touches energy, aging, recovery, cognition, and mitochondrial health. The page should avoid vague longevity language and instead explain the role of NAD+ in redox metabolism, sirtuins, PARPs, route differences, and why outcomes are hard to generalize.
Decision question for NAD+
Is the reader trying to solve a specific fatigue or recovery problem that deserves medical evaluation first?
Peptide evidence layer
Evidence read
The best NAD+ content should explain precursor versus direct-delivery claims, route of administration, age-related decline, mitochondrial context, and where human outcome evidence remains limited.
Safety watch
A review should check medication context, pregnancy status, cancer history, severe fatigue causes, sleep issues, anemia, thyroid disease, depression, and whether symptoms need diagnosis before supplementation.
Conversion fit
The next step should help readers decide whether NAD+ belongs in a supervised wellness plan or whether labs and medical workup should come first.
Last updated: April 3, 2026
Typical Dosage
IV infusion: 250-500 mg per session, 1-2 times per week during initial loading. Subcutaneous injection: 50-100 mg daily. Oral NMN/NR precursors: 250-1000 mg daily.
Administration
Intravenous infusion, Subcutaneous injection, Oral (as NMN or NR precursors), Nasal spray
Typical Cost
$150-500/month depending on route. IV infusions typically $250-750 per session.
FDA Status
Not FDA Approved
Half-Life
Plasma NAD+ is rapidly metabolized. IV infusion provides sustained elevation over the infusion period (typically 2-4 hours). Subcutaneous NAD+ has not been well-characterized pharmacokinetically.
Onset of Action
IV infusion raises NAD+ levels immediately during the infusion. Subcutaneous and oral precursor supplementation takes 1-2 weeks to show measurable NAD+ blood level increases.
Bioavailability
IV infusion bypasses first-pass metabolism for direct blood elevation. Oral NAD+ is poorly absorbed (precursors like NMN and NR are used instead for oral dosing).
About NAD+
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. It's not technically a peptide but is often grouped with peptide therapies in clinical practice. Molecular weight: 663.43 Da. CAS number: 53-84-9.
NAD+ is required for over 500 enzymatic reactions in the human body. It's a central player in energy metabolism (the mitochondrial electron transport chain can't function without it), DNA repair (PARP enzymes consume NAD+ to fix DNA breaks), and cellular aging regulation (sirtuins, the so-called longevity genes, require NAD+ as a co-substrate).
The core problem is that NAD+ levels decline significantly with age. A 2021 review in Nature Reviews Molecular Cell Biology (PMID: 33353981) established NAD+ decline as a hallmark of aging, linking it to mitochondrial dysfunction, accumulated DNA damage, and chronic inflammation. By age 60, most people have roughly half the NAD+ they had at 40.
This decline isn't just a biomarker. Animal studies consistently show that restoring NAD+ levels extends lifespan, improves metabolic function, and reverses age-related tissue decline in mice. The billion-dollar question is whether the same holds true in humans.
The human data is growing. A 2021 study published in Science (PMID: 33888596) tested NMN (an NAD+ precursor) in 25 postmenopausal women with prediabetes. After 10 weeks of 250 mg/day NMN, the treatment group showed improved muscle insulin sensitivity and skeletal muscle remodeling. A 2018 trial in Nature Communications (PMID: 29599478) confirmed that nicotinamide riboside (another precursor) safely raised blood NAD+ levels by 60% over 6 weeks in healthy middle-aged adults.
NAD+ therapy comes in several forms. IV infusion (250-500 mg over 2-4 hours) provides the most direct elevation but requires clinic visits and can cause significant nausea, flushing, and chest pressure during infusion. Subcutaneous injection (50-100 mg daily) is gaining popularity as a home-administered alternative. Oral precursors (NMN at 250-500 mg/day or NR at 300-1000 mg/day) are the most convenient option and are sold as dietary supplements.
The cost differences are marked: IV infusions run $250-1,000 per session, subcutaneous injections through compounding pharmacies cost $200-400/month, and oral NMN supplements range from $30-100/month.
One controversy worth mentioning: some researchers worry that NAD+ supplementation could fuel cancer growth, since rapidly dividing cells have high NAD+ demands. This is an active area of investigation. The current consensus is that NAD+ supplementation appears safe in people without active cancer, but patients undergoing cancer treatment should discuss it with their oncologist.
Store IV and injectable NAD+ refrigerated at 2-8C. Protect from light. Oral NMN and NR supplements can be stored at room temperature in a cool, dry place.
How NAD+ Works
NAD+ is an essential cofactor for sirtuins (SIRT1-7), PARP enzymes involved in DNA repair, and CD38, which regulates immune function. When NAD+ levels are restored through IV infusion, injection, or oral precursors, sirtuin activity increases, leading to improved mitochondrial biogenesis, better insulin sensitivity, and enhanced cellular stress responses. NAD+ also directly fuels the electron transport chain in mitochondria, improving ATP production.
Receptor targets:
Benefits
- Restores cellular energy production through mitochondrial support
- Activates sirtuins involved in DNA repair and longevity pathways
- Improves cognitive clarity and reduces brain fog
- Supports healthy metabolic function and insulin sensitivity
- May slow aspects of biological aging at the cellular level
- Enhances exercise performance and recovery
- Supports addiction recovery protocols (historically used in detox settings)
What Does the Research Say?
NAD+ has strong mechanistic science behind it and growing human clinical data. A 2022 randomized controlled trial published in Nature Aging showed that NMN supplementation (an NAD+ precursor) improved muscle insulin sensitivity in postmenopausal women. Several other human trials confirm NAD+ levels increase with supplementation. The longevity claims are still mostly based on animal models.
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
RCT in 25 postmenopausal prediabetic women showed NMN (250mg/day for 10 weeks) improved muscle insulin sensitivity and skeletal muscle remodeling
NAD+ metabolism and its roles in cellular processes during ageing
Nature Reviews Molecular Cell Biology, 2021 · DOI · PubMed
Complete review establishing NAD+ decline as a hallmark of aging and linking it to mitochondrial dysfunction, DNA damage accumulation, and inflammation
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
Nature Communications, 2018 · DOI · PubMed
First human trial of NR supplementation confirmed it safely raises NAD+ levels by 60% in blood over 6 weeks in middle-aged and older adults
PubMed evidence trail
Research sources used to frame this page
For NAD+, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not a claim that every study applies to every patient.
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Emerging pharmacotherapies for obesity: A systematic review
Broad context for new and established obesity-drug categories.
PubMed
Glucagon-like receptor agonists and next-generation incretin-based medications
Current review for incretin-based obesity medications and cardiometabolic effects.
PubMed
Potential Side Effects
- Nausea during IV infusion if administered too quickly
- Chest tightness or pressure during IV infusion
- Cramping
- Headache
- Flushing and warmth
Drug Interactions
| Compound | Interaction | Severity |
|---|---|---|
| Chemotherapy drugs | Some cancers rely on NAD+ for growth. Supplementing NAD+ during active cancer treatment could theoretically fuel tumor metabolism. This is an active area of research with no consensus. | major |
| Immunosuppressants | NAD+ modulates immune function through CD38 and sirtuin pathways. Supplementation could alter immune activity in transplant patients or those on immunosuppressive therapy. | moderate |
Who Is NAD+ For?
Women
The most relevant human RCT (NMN, 2021 Science paper) was specifically conducted in postmenopausal women, showing improved muscle insulin sensitivity. NAD+ decline accelerates around menopause.
Adults Over 50
This is the primary target population. NAD+ levels decline by roughly 50% between ages 40 and 60. The 2018 Nature Communications study confirmed safe elevation of NAD+ in middle-aged and older adults.
Athletes
Not banned by WADA. Used for recovery and energy metabolism. IV NAD+ drips are popular among endurance athletes for post-competition recovery.
Regulatory Status
FDA Approved
No
Compounding Legal
Yes
2026 HHS Status
Not affected by 2023 restrictions
NAD+ is available through compounding pharmacies for IV infusion and subcutaneous injection. Precursor forms (NMN, NR) are sold as dietary supplements without prescription.
Last verified: 2026-04-06
Stacking Options
NAD+ is commonly stacked with the following peptides for enhanced results:
Conditions Addressed
Get NAD+ from FormBlends
Pharmaceutical-grade nad+ with free physician consultation.
View Product DetailsFind a NAD+ Clinic Near You
Browse peptide therapy clinics in your area that offer nad+ treatments.
Find Peptide Clinics